C. D. Pendleton

发表

Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs.

J. Berzofsky, M. Shirai, M. Newman, 1994, Journal of immunology.

Induction of broadly cross-reactive cytotoxic T cells recognizing an HIV-1 envelope determinant.

R A Houghten, J. Berzofsky, R. Germain, 1992, Science.

Enhanced immunogenicity of HIV-1 vaccine construct by modification of the native peptide sequence.

J. Berzofsky, C. D. Pendleton, J. Ahlers, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Candidate HIV type 1 multideterminant cluster peptide-P18MN vaccine constructs elicit type 1 helper T cells, cytotoxic T cells, and neutralizing antibody, all using the same adjuvant immunization.

J. Berzofsky, M. Newman, C. D. Pendleton, 1996, AIDS research and human retroviruses.

Induction of cytotoxic T cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like protein

J. Berzofsky, R. Houghten, C. Wychowski, 1992, Journal of virology.

Antigenicity of fusion proteins from sarcoma-associated chromosomal translocations.

F. Marincola, J. Berzofsky, L. Helman, 2001, Cancer research.

A mutant p53 tumor suppressor protein is a target for peptide-induced CD8+ cytotoxic T-cells.

J. Berzofsky, J. Minna, D. Carbone, 1993, Cancer research.

Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules.

J. Berzofsky, M. Shirai, C. D. Pendleton, 1992, Journal of immunology.

Serum Angiotensin-1 Conver~_'ng Enzyme Activity Processes a Human Immunodeficiency Virus 1 gp160 Peptide for Presentation by Major Histocompatibility Complex Class I Molecules By Steven Kozlowski,* Maripat Corr,* Toshiyuki Takeshita,$

J. Berzofsky, R. Germain, D. Margulies, 1992 .

Serum angiotensin-1 converting enzyme activity processes a human immunodeficiency virus 1 gp160 peptide for presentation by major histocompatibility complex class I molecules

J. Berzofsky, R. Germain, D. Margulies, 1992, The Journal of experimental medicine.

Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule.

D. Margulies, S. Kozlowski, C. D. Pendleton, 1995, Journal of immunology.

Molecular analysis of presentation by HLA-A2.1 of a promiscuously binding V3 loop peptide from the HIV-envelope protein to human cytotoxic T lymphocytes.

J. Berzofsky, K. Parker, J. Coligan, 1996, International immunology.

Identification and epitope enhancement of a PAX-FKHR fusion protein breakpoint epitope in alveolar rhabdomyosarcoma cells created by a tumorigenic chromosomal translocation inducing CTL capable of lysing human tumors.

J. Berzofsky, L. Helman, C. Mackall, 2006, Cancer Research.

of TCR Specificity Between Peptide Residues in the Delineation The Importance of Pairwise Interactions

J. Berzofsky, Anita Kumar, G. Leggatt, 1998 .

Identification and Enhancement of HLA-A2.1-Restricted CTL Epitopes in a New Human Cancer Antigen-POTE

I. Pastan, J. Berzofsky, Yi‐Hsiang Huang, 2013, PloS one.

Possible Therapeutic Vaccine Strategy against Human Immunodeficiency Virus Escape from Reverse Transcriptase Inhibitors Studied in HLA-A2 Transgenic Mice

J. Berzofsky, R. Yarchoan, C. D. Pendleton, 2006, Journal of Virology.

Immunization with mutant p53- and K-ras-derived peptides in cancer patients: immune response and clinical outcome.

J. Berzofsky, J. Minna, D. Carbone, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Protective immunity provided by HLA-A2 epitopes for fusion and hemagglutinin proteins of measles virus.

J. Berzofsky, D. Burke, D. Griffin, 2006, Virology.

Epitope Enhancement of a CD4 HIV Epitope toward the Development of the Next Generation HIV Vaccine1

Takahiro Okazaki, Pablo Sarobe, J. Berzofsky, 2006, The Journal of Immunology.

The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition.

J. Berzofsky, R. Germain, R. Houghten, 1993, Journal of immunology.

An epitope in human immunodeficiency virus 1 reverse transcriptase recognized by both mouse and human cytotoxic T lymphocytes.

J. Berzofsky, B. Moss, R. Germain, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Construction of peptides encompassing multideterminant clusters of human immunodeficiency virus envelope to induce in vitro T cell responses in mice and humans of multiple MHC types.

J. Berzofsky, M. Clerici, G. Shearer, 1991, The Journal of clinical investigation.

Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions.

J. Berzofsky, V. Engelhard, P. Sarobe, 1998, The Journal of clinical investigation.

An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans

J. Berzofsky, R. Houghten, C. Wychowski, 1994, Journal of virology.

Multiple pathways are involved in the extracellular processing of MHC class I-restricted peptides.

J. Berzofsky, D. Margulies, M. Corr, 1993, Journal of immunology.

Approaches to improve engineered vaccines for human immunodeficiency virus and other viruses that cause chronic infections

J. Berzofsky, C. D. Pendleton, J. Ahlers, 1999, Immunological reviews.

Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 region

J. Berzofsky, M. Battegay, K. Kurokohchi, 1996, Journal of virology.

The importance of pairwise interactions between peptide residues in the delineation of TCR specificity.

J. Berzofsky, G. Leggatt, C. D. Pendleton, 1998, Journal of immunology.

Human CTLs to Wild-Type and Enhanced Epitopes of a Novel Prostate and Breast Tumor-Associated Protein, TARP, Lyse Human Breast Cancer Cells

I. Pastan, W. M. Linehan, J. Berzofsky, 2004, Cancer Research.

Epitope-Enhanced Conserved HIV-1 Peptide Protects HLA-A2-Transgenic Mice Against Virus Expressing HIV-1 Antigen

J. Berzofsky, F. Lemonnier, C. D. Pendleton, 2003, The Journal of Immunology.

Virus Expressing HIV-1 Antigen Protects HLA-A2-Transgenic Mice Against Epitope-Enhanced Conserved HIV-1 Peptide

J. Berzofsky, F. Lemonnier, C. D. Pendleton, 2003 .

Characterization of a helper T cell epitope recognized by mice of a low responder major histocompatibility type.

C. DeLisi, J. Cornette, J. Berzofsky, 1990, Molecular immunology.

Induction of a Mucosal Cytotoxic T-Lymphocyte Response by Intrarectal Immunization with a Replication-Deficient Recombinant Vaccinia Virus Expressing Human Immunodeficiency Virus 89.6 Envelope Protein

J. Berzofsky, P. Earl, B. Moss, 1998, Journal of Virology.

Construction of an HIV-1 peptide vaccine containing a multideterminant helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple MHC haplotypes after two immunizations.

J. Berzofsky, A. Minassian, C. D. Pendleton, 1993, Journal of immunology.

HIV Vaccine toward the Development of the Next Generation Epitope Enhancement of a CD4 HIV Epitope

J. Berzofsky, K. Thomas, P. Sarobe, 2012 .

Epitope Enhancement of a CD 4 HIV Epitope toward the Development of the Next Generation HIV Vaccine 1

J. Berzofsky, D. Schwartz, P. Sarobe, 2006 .

Generation HIV Vaccine toward the Development of the Next Epitope Enhancement of a CD4 HIV Epitope

J. Berzofsky, P. Sarobe, C. D. Pendleton, 2006 .

Peptides containing multideterminant clusters of human immunodeficiency virus envelope induce murine and human T-cell responses in diverse histocompatibility types.

J. Berzofsky, M. Clerici, G. Shearer, 1991, Transactions of the Association of American Physicians.

Reciprocal cytotoxic T lymphocyte cross-reactivity interactions between two major epitopes within HIV-1 gp160.

J. Berzofsky, D. Margulies, K. Kurokohchi, 1996, Journal of immunology.

Oncogenic mutations in ras create HLA-A2.1 binding peptides but affect their extracellular antigen processing.

J. Berzofsky, D. Carbone, M. Kelley, 1997, International immunology.